BibTex RIS Cite

Biological evaluation of some tetrazole derivatives as cholinesterase inhibitors

Year 2014, Volume: 4 Issue: 1, 1 - 4, 25.04.2014

Abstract

Objectives: In this study, we aimed to synthesize fourteen different 2-[(1-methyl-1H-tetrazole-5-yl) thio]-1-(substituted phenyl)ethanone derivatives (1–14) and to investigate their anticholinesterase activities.

Method: 1-(Substituted phenyl)-2-[(1-methyl-1H-tetrazol-5-yl) thio]ethanone compounds were synthesized by reacting 1-methyl-1H-tetrazol-5-thiol with some phenacyl bromide derivatives. The structures of the obtained compounds were elucidated using IR, 1H-NMR, 13C-NMR and FAB+-MS spectral data and elemental analyses results. Each derivative was evaluated for its ability to inhibit acetylcholinesterase (AChE) using a modification of Ellman’s spectrophotometric method.

Results: The compound 2 and 3 were found as the most active compounds due to their inhibitory effect on AChE with inhibition percentages of 29.56 and 24.38%.

Conclusion: The compounds with electron donating substituents methyl and chloro at the third position of phenyl residue have exhibited the highest anticholinesterase activity.

Key words: Tetrazole, cholinesterase inhibitors

References

  • McGleenon BM, Dynan KB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer’s disease. Br J Clin Pharmacol. 1999; 48(4): 471-4
  • Katzman R, Saitoh T. Advances in Alzheimer’s Disease. FASEB J. 1991; 5: 278-286.
  • Becker RE. Therapy of the cognitive deficit in Alzheimer’s disease; the cholinergic system. In: Becker RE, Giacobini E, eds. Cholinergic Basis of Alzheimer Therapy. Boston: Berkhauser; 1991.
  • Cutler NR, Sramek JJ, Veroff AE. Alzheimer’s disease. The problem and search for solutions. In: Cutler NR, Sramek JJ, Veroff AE, (eds). Alzheimer’s Disease Optimizing Drug Development Strategies. Chichester: John Wiley and Sons; 1994. p.2-9.
  • Myznikov LV, Hrabalek A, Koldobskii GI. Drugs in the tetrazole serie. Chem Heterocycl Compd. 2007; 43: 1-9.
  • Ortar G, Moriello AS, Cascio MG, De Petrocellis L, Ligresti A, Morera E, Nalli M, Di Marzo V. New tetrazole-based selective anandamide uptake inhibitors. Bioorg Med Chem Lett. 2008; 18: 2820-2824.
  • Fürmeier S, Metzger JO. 5,5’-(p-Phenylene)di-1H-tetrazol. Eur J Org Chem. 2003; 5: 885-893.
  • Figueiredo JA, Ismael MI, Pinheiro JM, Silva AMS, Justino J, Silva FVM, Goulart M, Mira D, Araşjo MEM, Campoy R, Rauter AP. Facile synthesis of oxo-/thioxopyrimidines and tetrazoles C–C linked to sugars as novel non-toxic antioxidant acetylcholinesterase inhibitor. Carbohydr Res. 2012; 347: 47-54.
  • Bliznets I, Vasil´ev A, Shorshnev S, Stepanov A, Lukyanov S. Microwave-assisted synthesis of sterically hindered 3-(5-tetrazolyl) pyridines. Tetrahedron Lett. 2004; 45: 2571-2573.
  • Demko ZP, Sharpless KB, Angew A. Click chemistry approach to tetrazoles by Huisgen 1,3-dipolar cycloaddition: Synthesis of 5-sulfonyl tetrazoles from azides and sulfonyl cyanides. Chem Int Ed. 2002; 41: 2110-2113.
  • Dondoni A, Massi A. Decoration of dihydropyrimidine and dihydropyridine scaffolds with sugars via Biginelli and Hantzsch multicomponent reactions: An efficient entry to a collection of artificial nucleosides. Mol Divers. 2003; 6: 261-270.
  • Ostrowski S, Swat J, Makosza M. A preparative method for synthesis of 4,5,6-trichloropyrimidine. Arkivoc. 2000; 6: 905-908.
  • Kaplancikli ZA, Yurttas L, Ozdemir A, Turan-Zitouni G, Işcan G, Akalın G, Abu Mohsen U. Synthesis, anticandidal activity and cytotoxicity of some tetrazole derivatives J Enzym Inhib Med Chem. In press. (DOI:1 0.3109/14756366.2012.752363).
  • Perry NSL, Houghton PJ, Theobald AE, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholine esterase by Salvia lavandulae folia essential oil and constituent terpenes. J Pharm Pharmacol. 2000; 52: 895-902.
  • Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7: 88-95.

Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi

Year 2014, Volume: 4 Issue: 1, 1 - 4, 25.04.2014

Abstract

Amaç: Bu çalışmada, ondört farklı 2-[(1-metil-1H-tetrazol-5-il)tiyo]-1-(sübstitüe fenil) etanon (1–14) türevinin sentezleri ve antikolinesteraz aktivitelerinin araştırılması amaçlandı. 

Yöntem: 1-(Sübstitüe fenil)-2-[(1-metil-1H-tetrazol-5-il) tiyo]etanon (1–14) türevi bileşikler, 1-metil-1H-tetrazol-5-tiyol ile bazı fenaçil bromür türevlerinin reaksiyonuyla sentezlenmiştir. Bileşiklerin kimyasal yapıları, IR, 1H-NMR, 13C-NMR ve FAB+-MS spektral verileri ve elementel analiz verileri ile aydınlatılmıştır. Tüm türevlerin asetilkolinesteraz enzimini (AChE) inhibisyon yetenekleri modifiye Ellman spektrofotometrik metodu kullanılarak değerlendirilmiştir.

Bulgular: Bileşik 2 ve 3 AChE üzerinde %29.56 ve %24.38 inhibisyon oranları ile en aktif bileşikler olarak bulunmuştur.

Sonuç: Bileşiklerden fenil artığı üzerinde 3-konumunda elektron verici metil ve kloro sübstitüentleri içerenler en yüksek antikolinesteraz aktivite göstermişlerdir.

Anahtar Kelimeler : Tetrazol, kolinesteraz inhibitörleri

References

  • McGleenon BM, Dynan KB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer’s disease. Br J Clin Pharmacol. 1999; 48(4): 471-4
  • Katzman R, Saitoh T. Advances in Alzheimer’s Disease. FASEB J. 1991; 5: 278-286.
  • Becker RE. Therapy of the cognitive deficit in Alzheimer’s disease; the cholinergic system. In: Becker RE, Giacobini E, eds. Cholinergic Basis of Alzheimer Therapy. Boston: Berkhauser; 1991.
  • Cutler NR, Sramek JJ, Veroff AE. Alzheimer’s disease. The problem and search for solutions. In: Cutler NR, Sramek JJ, Veroff AE, (eds). Alzheimer’s Disease Optimizing Drug Development Strategies. Chichester: John Wiley and Sons; 1994. p.2-9.
  • Myznikov LV, Hrabalek A, Koldobskii GI. Drugs in the tetrazole serie. Chem Heterocycl Compd. 2007; 43: 1-9.
  • Ortar G, Moriello AS, Cascio MG, De Petrocellis L, Ligresti A, Morera E, Nalli M, Di Marzo V. New tetrazole-based selective anandamide uptake inhibitors. Bioorg Med Chem Lett. 2008; 18: 2820-2824.
  • Fürmeier S, Metzger JO. 5,5’-(p-Phenylene)di-1H-tetrazol. Eur J Org Chem. 2003; 5: 885-893.
  • Figueiredo JA, Ismael MI, Pinheiro JM, Silva AMS, Justino J, Silva FVM, Goulart M, Mira D, Araşjo MEM, Campoy R, Rauter AP. Facile synthesis of oxo-/thioxopyrimidines and tetrazoles C–C linked to sugars as novel non-toxic antioxidant acetylcholinesterase inhibitor. Carbohydr Res. 2012; 347: 47-54.
  • Bliznets I, Vasil´ev A, Shorshnev S, Stepanov A, Lukyanov S. Microwave-assisted synthesis of sterically hindered 3-(5-tetrazolyl) pyridines. Tetrahedron Lett. 2004; 45: 2571-2573.
  • Demko ZP, Sharpless KB, Angew A. Click chemistry approach to tetrazoles by Huisgen 1,3-dipolar cycloaddition: Synthesis of 5-sulfonyl tetrazoles from azides and sulfonyl cyanides. Chem Int Ed. 2002; 41: 2110-2113.
  • Dondoni A, Massi A. Decoration of dihydropyrimidine and dihydropyridine scaffolds with sugars via Biginelli and Hantzsch multicomponent reactions: An efficient entry to a collection of artificial nucleosides. Mol Divers. 2003; 6: 261-270.
  • Ostrowski S, Swat J, Makosza M. A preparative method for synthesis of 4,5,6-trichloropyrimidine. Arkivoc. 2000; 6: 905-908.
  • Kaplancikli ZA, Yurttas L, Ozdemir A, Turan-Zitouni G, Işcan G, Akalın G, Abu Mohsen U. Synthesis, anticandidal activity and cytotoxicity of some tetrazole derivatives J Enzym Inhib Med Chem. In press. (DOI:1 0.3109/14756366.2012.752363).
  • Perry NSL, Houghton PJ, Theobald AE, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholine esterase by Salvia lavandulae folia essential oil and constituent terpenes. J Pharm Pharmacol. 2000; 52: 895-902.
  • Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7: 88-95.
There are 15 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Usama Abu Mohsen This is me

Leyla Yurttaş This is me

Ahmet Özdemir This is me

Gülhan Turan-zitouni This is me

Zafer Asim Kaplancikli This is me

Publication Date April 25, 2014
Submission Date April 25, 2014
Published in Issue Year 2014 Volume: 4 Issue: 1

Cite

APA Abu Mohsen, U., Yurttaş, L., Özdemir, A., Turan-zitouni, G., et al. (2014). Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi. Clinical and Experimental Health Sciences, 4(1), 1-4.
AMA Abu Mohsen U, Yurttaş L, Özdemir A, Turan-zitouni G, Kaplancikli ZA. Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi. Clinical and Experimental Health Sciences. December 2014;4(1):1-4.
Chicago Abu Mohsen, Usama, Leyla Yurttaş, Ahmet Özdemir, Gülhan Turan-zitouni, and Zafer Asim Kaplancikli. “Bazı Tetrazol türevlerinin Kolinesteraz inhibitörü Olarak Biyolojik açıdan değerlendirilmesi”. Clinical and Experimental Health Sciences 4, no. 1 (December 2014): 1-4.
EndNote Abu Mohsen U, Yurttaş L, Özdemir A, Turan-zitouni G, Kaplancikli ZA (December 1, 2014) Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi. Clinical and Experimental Health Sciences 4 1 1–4.
IEEE U. Abu Mohsen, L. Yurttaş, A. Özdemir, G. Turan-zitouni, and Z. A. Kaplancikli, “Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi”, Clinical and Experimental Health Sciences, vol. 4, no. 1, pp. 1–4, 2014.
ISNAD Abu Mohsen, Usama et al. “Bazı Tetrazol türevlerinin Kolinesteraz inhibitörü Olarak Biyolojik açıdan değerlendirilmesi”. Clinical and Experimental Health Sciences 4/1 (December 2014), 1-4.
JAMA Abu Mohsen U, Yurttaş L, Özdemir A, Turan-zitouni G, Kaplancikli ZA. Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi. Clinical and Experimental Health Sciences. 2014;4:1–4.
MLA Abu Mohsen, Usama et al. “Bazı Tetrazol türevlerinin Kolinesteraz inhibitörü Olarak Biyolojik açıdan değerlendirilmesi”. Clinical and Experimental Health Sciences, vol. 4, no. 1, 2014, pp. 1-4.
Vancouver Abu Mohsen U, Yurttaş L, Özdemir A, Turan-zitouni G, Kaplancikli ZA. Bazı tetrazol türevlerinin kolinesteraz inhibitörü olarak biyolojik açıdan değerlendirilmesi. Clinical and Experimental Health Sciences. 2014;4(1):1-4.

14639   14640